BiotechTube
Home/Vividion Therapeutics/Matt Patricelli
MP

Matt Patricelli

Chief Scientific Officer

Vividion Therapeutics

Therapeutic Areas

OncologyImmunological Diseases

Vividion Therapeutics Pipeline

DrugIndicationPhase
VVD-214/RO7589831MSI-High CancersPhase 1
KEAP1 Activator ProgramOncologyPhase 1

Leadership Team at Vividion Therapeutics

AR
Aleksandra Rizo
President and Chief Executive Officer
View full Vividion Therapeutics profile